Brief: EMA Says Sanofi Winthrop Industrie Withdrew Its Application For Use Of Dupixent On June 24
BRIEF-EMA Says Sanofi Winthrop Industrie Withdrew Its Application For Use Of Dupixent On June 24 Aug 18 (Reuters) - EMA:
EMA: SANOFI WINTHROP INDUSTRIE WITHDREW ITS APPLICATION FOR USE OF DUPIXENT ON 24 JUNE 2026
EMA: SANOFI WINTHROP INDUSTRIE WITHDRAWS DUPIXENT APPLICATION DUE TO DIVERGENCE OF VIEWS WITH CHMP
EMA: DIVERGENCE OF VIEWS WITH CHMP REGARDING SUFFICIENCY OF DATA SUPPORTING PROPOSED EXTENSION OF USE FOR DUPIXENT
Further company coverage: SASY.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi SA
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
EdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments